DENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue fell 4.06%, EPS grew 181.8%, free cash flow grew 252.9% and total debt fell 10.0%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.
Follow XRAY
DENTSPLY SIRONA Inc. (XRAY) EV/Sales
As of 16 October 2026, DENTSPLY SIRONA Inc. (XRAY) trades at a EV/Sales of 1.0×. Over the past ten years it has ranged from 0.9× (October 2026) to 5.2× (August 2016); the current reading is higher than 0% of that period. That is below the Medical Instruments & Supplies industry median of 2.9× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.1× | (20.90%) |
| FY2024 | 1.4× | (40.05%) |
| FY2023 | 2.3× | 4.85% |
| FY2022 | 2.2× | (33.31%) |
| FY2021 | 3.3× | (16.59%) |
| FY2020 | 3.9× | 14.85% |
| FY2019 | 3.4× | 40.92% |
| FY2018 | 2.4× | (42.37%) |
| FY2017 | 4.2× | 12.58% |
| FY2016 | 3.7× | 5.91% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.1× | (5.29%) |
| Mar 2026 | 1.1× | 4.17% |
| Dec 2025 | 1.1× | (6.64%) |
| Sep 2025 | 1.2× | (15.60%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| XRAY DENTSPLY SIRONA Inc. | 1.0× |
| NVST Envista Holdings Corporation compare | 1.4× |
| AZTA Azenta, Inc. compare | 2.1× |
| STAA STAAR Surgical Company compare | 2.7× |
| WRBY Warby Parker Inc. compare | 2.9× |
| ATRC AtriCure, Inc. compare | 4.7× |
| LMAT LeMaitre Vascular, Inc. compare | 6.3× |
| KMTS Kestra Medical Technologies, Ltd. compare | 13.8× |
| PLSE Pulse Biosciences, Inc compare | 2,555× |
| Medical Instruments & Supplies industry median | 2.9× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)